Praxis Precision Medicines Stock Today
| PRAX Stock | USD 37.12 0.57 1.51% |
PerformanceVery Weak
| Odds Of DistressAbove Average
|
Praxis Precision is trading at 37.12 as of the 24th of March 2025; that is 1.51 percent decrease since the beginning of the trading day. The stock's open price was 37.69. Praxis Precision has over 58 % chance of experiencing financial distress in the next 2 years of operation and has generated negative returns for investors over the last 90 days. The performance scores are derived for the period starting the 24th of December 2024 and ending today, the 24th of March 2025. Click here to learn more.
Praxis Precision Medicines, Inc., a clinical-stage biopharmaceutical company, develops therapies for central nervous system disorders characterized by neuronal imbalance. The company was incorporated in 2015 and is based in Boston, Massachusetts. Praxis Precision operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. The company has 20.16 M outstanding shares of which 2.67 M shares are at this time shorted by private and institutional investors with about 3.57 trading days to cover. More on Praxis Precision Medicines
Moving against Praxis Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Praxis Stock Highlights
| CEO President | Marcio MBA |
| Business Concentration | Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, NASDAQ Biotechnology, NASDAQ Composite, NASDAQ Health Care, Health Care, Biotechnology, Biotechnology, Healthcare (View all Sectors) |
Praxis Precision Medicines (PRAX) is traded on NASDAQ Exchange in USA. It is located in 99 High Street, Boston, MA, United States, 02110 and employs 116 people. Praxis Precision is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Small-Cap' category with a current market capitalization of 748.46 M. Praxis Precision Med conducts business under Biotechnology sector and is part of Health Care industry. The entity has 20.16 M outstanding shares of which 2.67 M shares are at this time shorted by private and institutional investors with about 3.57 trading days to cover.
Praxis Precision Medicines currently holds about 165.4 M in cash with (131.76 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.7.
Check Praxis Precision Probability Of Bankruptcy
Ownership AllocationThe majority of Praxis Precision Medicines outstanding shares are owned by third-party entities. These institutional holders are usually referred to as non-private investors looking to secure positions in Praxis Precision Med to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Praxis Precision. Please pay attention to any change in the institutional holdings of Praxis Precision Med as this could imply that something significant has changed or is about to change at the company.
Check Praxis Ownership Details
Praxis Precision Med Risk Profiles
Investors will always prefer to have the highest possible return on investment while minimizing volatility. Praxis Precision market risk premium is the additional return an investor will receive from holding Praxis Precision long position in a well-diversified portfolio.
| Risk Adjusted Performance | (0.11) | |||
| Jensen Alpha | (0.92) | |||
| Total Risk Alpha | (0.38) | |||
| Treynor Ratio | 56.44 |
Praxis Stock Against Markets
Praxis Precision Corporate Management
| Dr B | CoFounder Officer | Profile | |
| Timothy Kelly | CFO Treasurer | Profile | |
| Nicole Sweeny | Chief Officer | Profile | |
| Kelly McCue | Chief Officer | Profile | |
| Alyssa Wyant | Chief Officer | Profile | |
| Megan Sniecinski | Chief Officer | Profile | |
| Lauren Mastrocola | VP Officer | Profile |
Additional Tools for Praxis Stock Analysis
When running Praxis Precision's price analysis, check to measure Praxis Precision's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Praxis Precision is operating at the current time. Most of Praxis Precision's value examination focuses on studying past and present price action to predict the probability of Praxis Precision's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Praxis Precision's price. Additionally, you may evaluate how the addition of Praxis Precision to your portfolios can decrease your overall portfolio volatility.